Publications by authors named "H Ueki"

Microthrombus formation is associated with COVID-19 severity; however, the detailed mechanism remains unclear. In this study, we investigated mouse models with severe pneumonia caused by SARS-CoV-2 infection by using our in vivo two-photon imaging system. In the lungs of SARS-CoV-2-infected mice, increased expression of adhesion molecules in intravascular neutrophils prolonged adhesion time to the vessel wall, resulting in platelet aggregation and impaired lung perfusion.

View Article and Find Full Text PDF

Since early 2024, highly pathogenic avian influenza H5N1 viruses have been causing outbreaks in dairy cattle in the United States. Here, we compared the replicative capacity of A/dairy cattle/Texas/24-008749-001/2024 (H5N1; Cow-H5N1) isolated from a dairy cow, A/chicken/Ghana/AVL-76321VIR7050-39/2021 (H5N1; Chicken-H5N1) isolated from a chicken, and a human H1N1 2009 pandemic virus in ex vivo explant cultures of mammary gland and teat from lactating cows. We also examined the expression of influenza virus receptors in these organs.

View Article and Find Full Text PDF

Background/objectives: Extended pelvic lymph node dissection is a crucial surgical technique for managing intermediate to high-risk prostate cancer. Accurately predicting lymph node metastasis before surgery can minimize unnecessary lymph node dissections and their associated complications. This study assessed the efficacy of various machine learning models for predicting lymph node metastasis in a cohort of Japanese patients who underwent robot-assisted laparoscopic radical prostatectomy.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the effectiveness of neoadjuvant therapy in improving outcomes for patients with non-metastatic renal cell carcinoma (RCC) accompanied by inferior vena cava (IVC) thrombus prior to surgical resection.
  • Data from 2006 to 2024 showed that patients receiving neoadjuvant therapy had smaller tumor sizes and better survival rates compared to those who did not receive this treatment.
  • Findings indicate that neoadjuvant therapy can lead to significantly improved disease-free survival (DFS) and overall survival (OS) for these patients, highlighting its potential as a beneficial preoperative treatment option.
View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to explore how tumor size affects the prognosis of patients with metastatic renal cell carcinoma (mRCC) receiving two different treatment approaches: dual immune checkpoint inhibitors (IOIO) and a combination of immune checkpoint inhibitors with tyrosine kinase inhibitors (IOTKI).
  • Researchers analyzed data from 180 mRCC patients to evaluate the impact of tumor size on progression-free survival (PFS) and overall survival (OS), finding that it was a significant predictor especially in the IOIO group.
  • The results suggest that tumor size should be prioritized in treatment decisions for renal cancer, particularly for patients undergoing IOIO therapy, as it offered better prognostic insights than other factors like nephrectomy status and IMDC risk classification
View Article and Find Full Text PDF